378
Views
62
CrossRef citations to date
0
Altmetric
HCG

Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial

, , , , &
Pages 60-66 | Received 16 Jun 2008, Accepted 12 Aug 2008, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Benjamin P. Jones, Ali Al-Chami, Xavier Gonzalez, Falak Arshad, Joy Green, Timothy Bracewell-Milnes, Srdjan Saso, Richard Smith, Paul Serhal & Jara Ben Nagi. (2021) Is oocyte maturity influenced by ovulation trigger type in oocyte donation cycles?. Human Fertility 24:5, pages 360-366.
Read now
Juan Carlos Castillo, Thor Haahr, María Martínez-Moya & Peter Humaidan. (2020) Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention. Upsala Journal of Medical Sciences 125:2, pages 138-143.
Read now
Miguel A Checa, Mario Brassesco, Margalida Sastre, Manuel Gómez, Julio Herrero, Laura Marque, Arturo Brassesco & Juan José Espinós. (2015) Random-start GnRH antagonist for emergency fertility preservation: a self-controlled trial. International Journal of Women's Health 7, pages 219-225.
Read now

Articles from other publishers (59)

Diane M. Tober, Kevin Richter, Dougie Zubizarreta & Said Daneshmand. (2023) Egg donor self-reports of ovarian hyperstimulation syndrome: severity by trigger type, oocytes retrieved, and prior history. Journal of Assisted Reproduction and Genetics 40:6, pages 1291-1304.
Crossref
Jamie Merkison, Carrie Malcom & Alan Decherney. (2022) Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders. Frontiers in Endocrinology 13.
Crossref
Yueshuai Guo, Lingbo Cai, Xiaofei Liu, Long Ma, Hao Zhang, Bing Wang, Yaling Qi, Jiayin Liu, Feiyang Diao, Jiahao Sha & Xuejiang Guo. (2022) Single-Cell Quantitative Proteomic Analysis of Human Oocyte Maturation Revealed High Heterogeneity in In Vitro–Matured Oocytes. Molecular & Cellular Proteomics 21:8, pages 100267.
Crossref
Marcelle I Cedars. (2022) Evaluation of Female Fertility—AMH and Ovarian Reserve Testing. The Journal of Clinical Endocrinology & Metabolism 107:6, pages 1510-1519.
Crossref
P.P. Yakovlev & I.Yu. Kogan. (2022) Ovarian stimulation and oocyte quality. Problemy reproduktsii 28:3, pages 86.
Crossref
Molly Quinn, Marcelle I. Cedars, Heather G. Huddleston & Nanette Santoro. (2022) Antimüllerian hormone use and misuse in current reproductive medicine practice: a clinically oriented review. F&S Reviews 3:1, pages 1-10.
Crossref
Einat Haikin Herzberger, Sabaa Knaneh, Hadar Amir, Adi Reches, Dalit Ben-Yosef, Yael Kalma, Foad Azem & Nivin Samara. (2021) Gonadotropin-Releasing Hormone Agonist Versus Recombinant Human Chorionic Gonadotropin Triggering in Fertility Preservation Cycles. Reproductive Sciences 28:12, pages 3390-3396.
Crossref
Francisca Martinez, Annalisa Racca, Ignacio Rodríguez & Nikolaos P Polyzos. (2021) Ovarian stimulation for oocyte donation: a systematic review and meta-analysis. Human Reproduction Update 27:4, pages 673-696.
Crossref
Danilo Cimadomo, Alberto Vaiarelli, Cecilia Petriglia, Gemma Fabozzi, Susanna Ferrero, Mauro Schimberni, Cindy Argento, Silvia Colamaria, Maddalena Giuliani, Nicolò Ubaldi, Laura Rienzi & Filippo Maria Ubaldi. (2021) Oocyte competence is independent of the ovulation trigger adopted: a large observational study in a setting that entails vitrified-warmed single euploid blastocyst transfer. Journal of Assisted Reproduction and Genetics 38:6, pages 1419-1427.
Crossref
Pinelopi G. Ioannidou, Julia K. Bosdou, George T. Lainas, Tryfon G. Lainas, Grigoris F. Grimbizis & Efstratios M. Kolibianakis. (2021) How frequent is severe ovarian hyperstimulation syndrome after GnRH agonist triggering in high-risk women? A systematic review and meta-analysis. Reproductive BioMedicine Online 42:3, pages 635-650.
Crossref
Jacob Christ, Christopher N. Herndon & Bo Yu. (2021) Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients. Journal of Assisted Reproduction and Genetics 38:3, pages 751-756.
Crossref
Reeva Makhijani, Jeffrey Thorne, Chantal Bartels, Alison Bartolucci, John Nulsen, Daniel Grow, Claudio Benadiva & Lawrence Engmann. (2020) Pregnancy outcomes after frozen-thawed single euploid blastocyst transfer following IVF cycles using GNRH agonist or HCG trigger for final oocyte maturation. Journal of Assisted Reproduction and Genetics 37:3, pages 611-617.
Crossref
Yossi Mizrachi, Eran Horowitz, Jacob Farhi, Arieh Raziel & Ariel Weissman. (2020) Ovarian stimulation for freeze-all IVF cycles: a systematic review. Human Reproduction Update 26:1, pages 119-136.
Crossref
Jeffrey Thorne, Alexandra Loza, Leah Kaye, John Nulsen, Claudio Benadiva, Daniel Grow & Lawrence Engmann. (2019) Euploidy rates between cycles triggered with gonadotropin-releasing hormone agonist and human chorionic gonadotropin. Fertility and Sterility 112:2, pages 258-265.
Crossref
Basil C. Tarlatzis, Julia K. Bosdou & Efstratios M. Kolibianakis. 2019. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases 581 587 .
Valdivieso Pamela, Rodríguez José M, Troncoso E, Jiménez Juan M, Sánchez Fernando & Sánchez Pascual. (2018) Severe early ovarian hyperstimulation syndrome after spontaneous pregnancy and despite GnRH-agonist trigger during controlled ovarian stimulation in an oocyte donor cycle: a case report. Women's Health 7:5.
Crossref
Mindy S. Christianson & José Bellver. (2018) Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances. Fertility and Sterility 110:6, pages 994-1002.
Crossref
Shruti Parikh & Christophe Blockeel. 2018. Preventing Age Related Fertility Loss. Preventing Age Related Fertility Loss 125 139 .
Alicia Pérez-Calvo, Francisca Martínez, Christophe Blockeel, Elisabeth Clúa, Ignacio Rodríguez, Pere N. Barri & Buenaventura Coroleu. (2017) Importance of a 5- versus 7-day pill-free interval in a GnRH antagonist protocol using corifollitropin alfa: a prospective cohort study in oocyte donors. Reproductive BioMedicine Online 35:4, pages 425-431.
Crossref
Alberta Maria Fabris, M. Cruz, V. Legidos, C. Iglesias, M. Muñoz & J. A. García-Velasco. (2017) Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate. Reproductive Sciences 24:8, pages 1221-1225.
Crossref
Veljko Vlaisavljević, Borut Kovačič & Jure Knez. (2017) Cumulative live birth rate after GnRH agonist trigger and elective cryopreservation of all embryos in high responders. Reproductive BioMedicine Online 35:1, pages 42-48.
Crossref
Marcus J. Davenport, Beverley Vollenhoven & Alon J. Talmor. (2017) Gonadotropin-Releasing Hormone–Agonist Triggering and a Freeze-All Approach: The Final Step in Eliminating Ovarian Hyperstimulation Syndrome?. Obstetrical & Gynecological Survey 72:5, pages 296-308.
Crossref
Basil C. Tarlatzis, Julia Bosdou & Stratis Kolibianakis. 2017. Complications and Outcomes of Assisted Reproduction. Complications and Outcomes of Assisted Reproduction 149 163 .
Samantha Pfeifer, Samantha Butts, Daniel Dumesic, Gregory Fossum, Clarisa Gracia, Andrew La Barbera, Jennifer Mersereau, Randall Odem, Richard Paulson, Alan Penzias, Margareta Pisarska, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Michael Vernon & Eric Widra. (2016) Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertility and Sterility 106:7, pages 1634-1647.
Crossref
Christophe Blockeel, Panagiotis Drakopoulos, Samuel Santos-Ribeiro, Nikolaos P. Polyzos & Herman Tournaye. (2016) A fresh look at the freeze-all protocol: a SWOT analysis. Human Reproduction 31:3, pages 491-497.
Crossref
Lawrence Engmann, Claudio Benadiva & Peter Humaidan. (2016) GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. Reproductive BioMedicine Online 32:3, pages 274-285.
Crossref
Ernesto Bosch, Elena Labarta, Efstratios Kolibianakis, Mitchell Rosen & David Meldrum. (2016) Regimen of ovarian stimulation affects oocyte and therefore embryo quality. Fertility and Sterility 105:3, pages 560-570.
Crossref
M.A.F. Youssef, Hatem I. Abdelmoty, Mohamed A.S. Ahmed & Maged Elmohamady. (2015) GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis. Journal of Advanced Research 6:3, pages 341-349.
Crossref
C. O. Nastri, D. M. Teixeira, R. M. Moroni, V. M. S. Leitão & W. P. Martins. (2015) Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound in Obstetrics & Gynecology 45:4, pages 377-393.
Crossref
Mala Arora & Ritika Arora. 2015. Principles and Practice of Controlled Ovarian Stimulation in ART. Principles and Practice of Controlled Ovarian Stimulation in ART 405 416 .
Adrija Kumar Datta, Abey Eapen, Heidi Birch, Anitha Kurinchi-Selvan & Gillian Lockwood. (2014) Retrospective comparison of GnRH agonist trigger with HCG trigger in GnRH antagonist cycles in anticipated high-responders. Reproductive BioMedicine Online 29:5, pages 552-558.
Crossref
Mohamed AFM Youssef, Fulco Van der Veen, Hesham G Al-Inany, Monique H Mochtar, Georg Griesinger, Mohamed Nagi Mohesen, Ismail Aboulfoutouh & Madelon van Wely. (2014) Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database of Systematic Reviews.
Crossref
Peter Humaidan & Birgit Alsbjerg. (2014) GnRHa trigger for final oocyte maturation: is HCG trigger history?. Reproductive BioMedicine Online 29:3, pages 274-280.
Crossref
Juan Carlos Castillo, Peter Humaidan & Rafael Bernabéu. (2014) Pharmaceutical Options for Triggering of Final Oocyte Maturation in ART. BioMed Research International 2014, pages 1-7.
Crossref
David Reichman & Zev Rosenwaks. 2014. Human Fertility. Human Fertility 289 304 .
S. Iliodromiti, C. Blockeel, K. P. Tremellen, R. Fleming, H. Tournaye, P. Humaidan & S. M. Nelson. (2013) Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Human Reproduction 28:9, pages 2529-2536.
Crossref
Pilar Alama, Jose Bellver, Carmen Vidal & Juan Giles. (2013) GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome. International Journal of Endocrinology and Metabolism 11:2.
Crossref
N. E. Kummer, R. S. Feinn, D. W. Griffin, J. C. Nulsen, C. A. Benadiva & L. L. Engmann. (2012) Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger. Human Reproduction 28:1, pages 152-159.
Crossref
Daniel Bodri. 2013. Principles of Oocyte and Embryo Donation. Principles of Oocyte and Embryo Donation 205 219 .
SHAHAR KOL, ROY HOMBURG, BIRGIT ALSBJERG & PETER HUMAIDAN. (2012) The gonadotropin‐releasing hormone antagonist protocol – the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation. Acta Obstetricia et Gynecologica Scandinavica 91:6, pages 643-647.
Crossref
Nikolaos P. Polyzos, Dominic Stoop, Christophe Blockeel, Paul Adriaensen, Peter Platteau, Ellen Anckaert, Johan Smitz & Paul Devroey. (2012) Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors. Reproductive BioMedicine Online 24:5, pages 532-539.
Crossref
P. Humaidan, S. Kol, C. Benadiva, L. Engmann & E.G. Papanikolaou. (2012) Reply: GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Human Reproduction Update 18:2, pages 229-230.
Crossref
T. Imbar, S. Kol, F. Lossos, Y. Bdolah, A. Hurwitz & R. Haimov-Kochman. (2012) Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support. Human Reproduction 27:3, pages 753-759.
Crossref
Tarek K. Al-Hussaini. (2012) OHSS-free IVF practice: Dream or reality. Middle East Fertility Society Journal 17:1, pages A1-A3.
Crossref
J.C. Castillo, M. Dolz, J. Moreno, L. Gijón, R. Ferrer, E. Ferrero & F. Bonilla-Musoles. (2012) Triggering with GnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation. Reproductive BioMedicine Online 24:2, pages 247-250.
Crossref
Francisca Martínez, Laura Latre, Elisabet Clua, Ignacio Rodriguez & Buenaventura Coroleu. (2011) Replacing GnRH agonists with GnRH antagonists in oocyte recipient cycle did not adversely affect the pregnancy rates. European Journal of Obstetrics & Gynecology and Reproductive Biology 159:2, pages 355-358.
Crossref
P. Humaidan, S. Kol & E. Papanikolaou. (2011) GnRH agonist for triggering of final oocyte maturation: time for a change of practice?. Human Reproduction Update 17:4, pages 510-524.
Crossref
Shweta R. Nayak & Anthony N. Wakim. (2011) Random-start gonadotropin-releasing hormone (GnRH) antagonist–treated cycles with GnRH agonist trigger for fertility preservation. Fertility and Sterility 96:1, pages e51-e54.
Crossref
Nicole Kummer, Claudio Benadiva, Richard Feinn, Jessica Mann, John Nulsen & Lawrence Engmann. (2011) Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist. Fertility and Sterility 96:1, pages 63-68.
Crossref
Mohamed AFM Youssef, Fulco Van der Veen, Hesham G Al-Inany, Georg Griesinger, Monique H Mochtar, Ismail Aboulfoutouh, Sherif M. Khattab & Madelon van Wely. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Daniel Bodri, Sesh Kamal Sunkara & Arri Coomarasamy. (2011) Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis. Fertility and Sterility 95:1, pages 164-169.
Crossref
Georg Griesinger & Efstratios Kolibianakis. 2011. Ovarian Stimulation. Ovarian Stimulation 233 243 .
. 2011. Ovarian Stimulation. Ovarian Stimulation 217 261 .
Mohamed AFM Youssef, Fulco Van der Veen, Hesham G Al-Inany, Georg Griesinger, Monique H Mochtar & Madelon van Wely. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Fracisca Martínez, Elisabeth Clua, Paula Santmartí, Montserrat Boada, Ignacio Rodriguez & Buenaventura Coroleu. (2010) Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors. Fertility and Sterility 94:6, pages 2433-2436.
Crossref
Daniel Bodri, Juan José Guillén, Marta Trullenque, Katja Schwenn, Carolina Esteve & Oriol Coll. (2010) Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. Fertility and Sterility 93:7, pages 2418-2420.
Crossref
Georg Griesinger, Henriette Berndt, Laura Schultz, Marion Depenbusch & Askan Schultze-Mosgau. (2010) Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: A prospective, clinical cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology 149:2, pages 190-194.
Crossref
Carolina O. Nastri, Rui A. Ferriani, Isa A. Rocha & Wellington P. Martins. (2010) Ovarian hyperstimulation syndrome: pathophysiology and prevention. Journal of Assisted Reproduction and Genetics 27:2-3, pages 121-128.
Crossref
Albert Obradors, Mariona Rius, Juliana Cuzzi, Gemma Daina, Cristina Gutiérrez-Mateo, Aïda Pujol, Fernando Marina, Carmen Márquez, Jordi Benet & Joaquima Navarro. (2010) Errors at mitotic segregation early in oogenesis and at first meiotic division in oocytes from donor females: Comparative genomic hybridization analyses in metaphase II oocytes and their first polar body. Fertility and Sterility 93:2, pages 675-679.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.